Novartis may have a buyer for $21B generics unit Sandoz: report kdunleavy Mon, 11/22/2021 – 16:28 More: Novartis may have a buyer for B generics unit Sandoz: report Source: fierce
read moreSagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging glitch fkansteiner Mon, 11/22/2021 – 13:34 More: Sagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging glitch Source: fierce
read moreEsoCap swallows up VC cash to fuel study of topical delivery to the esophagus ntaylor Mon, 11/22/2021 – 11:47 More: EsoCap swallows up VC cash to fuel study of topical delivery to the esophagus Source: fierce
read moreTopical treatment for chemotherapy pain clears early clinical test, teeing up further study of alternative to oral options ntaylor Mon, 11/22/2021 – 11:41 More: Topical treatment for chemotherapy pain clears early clinical test, teeing up further study of alternative to
read moreAmgen’s Otezla, Repatha and biosimilars put on notice, with challenging years ahead aliu Mon, 11/22/2021 – 11:19 More: Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead Source: fierce
read moreThe approval of Covaxin follows the WHO Emergency Use Listing for the vaccine More: UK recognises Covaxin as valid COVID-19 vaccine for travel Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals